Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 27
Filter
1.
Ann Allergy Asthma Immunol ; 108(6): 412-7, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22626593

ABSTRACT

BACKGROUND: Several studies have been performed reviewing medical examiner's autopsy reports of asthma deaths. None, to our knowledge, have focused on the characteristics of asthma deaths in the urban community alone. OBJECTIVE: To characterize factors related to asthma deaths occurring outside the hospital setting in an urban community. METHODS: We reviewed the medical records of 22 patients who died outside the hospital of asthma and underwent autopsy performed by the Milwaukee County medical examiner from 2004 to 2008. RESULTS: The mean age of the patients was 32 years (range, 12-71 years), 11 patients were male, and 14 patients (64%) were African American. Seventeen patients (77%) died during the night or shortly on awakening. Twelve patients (55%) died in June, July, or August. A history of illicit drug, alcohol, or tobacco use was discovered in 13 patients (59%). Toxicologic test results for drugs of abuse were positive in 4 patients (18%). Twenty patients were using or overusing a short-acting ß-agonist, 1 patient was taking omalizumab, and none were taking long-acting ß-agonists alone. Two patients were taking no medications. Asthma severity and medication adherence were not consistently reported. Lung pathologic testing revealed eosinophils in 18 patients and a lack of neutrophils in every case. CONCLUSION: In this small and limited series of asthma deaths occurring in an urban setting outside the hospital, individuals were more likely to be African Americans, with deaths occurring more frequently at night, during the summer months, and in those with substance abuse and not taking anti-inflammatory asthma medications.


Subject(s)
Asthma/mortality , Black or African American , White People , Adolescent , Adult , Aged , Asthma/complications , Asthma/drug therapy , Asthma/ethnology , Autopsy , Child , Female , Humans , Male , Middle Aged , Patient Compliance , Retrospective Studies , Seasons , Substance-Related Disorders/complications , Substance-Related Disorders/drug therapy , Substance-Related Disorders/ethnology , Substance-Related Disorders/mortality , Urban Population , Wisconsin/epidemiology
2.
Immunol Allergy Clin North Am ; 31(4): 769-86, vii, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21978856

ABSTRACT

Hypersensitivity pneumonitis can occur from a wide variety of occupational exposures. Although uncommon and difficult to recognize, through a detailed work exposure history, physical examination, radiography, pulmonary function studies, and selected laboratory studies using sera and bronchoalveolar lavage fluid, workers can be identified early to effect avoidance of the antigen and institute pharmacologic therapy, if necessary. A lung biopsy may be necessary to rule out other interstitial lung diseases. Despite the varied organic antigen triggers, the presentation is similar with acute, subacute, or chronic forms. Systemic corticosteroids are the only reliable pharmacologic treatment but do not alter the long-term outcome.


Subject(s)
Agriculture , Alveolitis, Extrinsic Allergic/diagnosis , Berylliosis/diagnosis , Food Industry , Industry , Occupational Exposure/prevention & control , Pneumoconiosis/diagnosis , Silicosis/diagnosis , Adrenal Cortex Hormones/administration & dosage , Adrenal Cortex Hormones/therapeutic use , Aerosols/adverse effects , Alveolitis, Extrinsic Allergic/classification , Alveolitis, Extrinsic Allergic/drug therapy , Alveolitis, Extrinsic Allergic/immunology , Alveolitis, Extrinsic Allergic/pathology , Berylliosis/immunology , Berylliosis/pathology , Biopsy , Diagnosis, Differential , Dust , Humans , Immunoglobulins/analysis , Immunoglobulins/biosynthesis , Lung/immunology , Lung/pathology , Lymphocytes/drug effects , Lymphocytes/immunology , Macrophages, Alveolar/drug effects , Macrophages, Alveolar/immunology , Pneumoconiosis/immunology , Pneumoconiosis/pathology , Respiratory Function Tests , Severity of Illness Index , Silicosis/immunology , Silicosis/pathology , Workplace
3.
Allergy Asthma Proc ; 29(4): 376-9, 2008.
Article in English | MEDLINE | ID: mdl-18702884

ABSTRACT

Occupational asthma (OA) accounts for 5-10% of all asthma in adults. Although OA secondary to enzymes has been reported, it is rare in the context of food preparation. In the cheese production industry, multiple powdered enzymes are used to soften and flavor cheese. Work-related asthma secondary to enzymes used in this manner has not been previously reported. We present two cases of OA after exposure to airborne enzyme powders used in cheese production. Both patients were adult women without histories of asthma who worked in a facility that used fungal and pancreatic-based enzymes to soften and flavor cheese. Both developed asthma symptoms within 1 year of employment and experienced relief of symptoms away from work. One patient had occupational rhinitis. Each underwent allergy skin testing, chest radiograph, pulmonary function testing, and methacholine challenge. Both patients had markedly positive skin tests to multiple enzyme antigens used at work. Spirometry, lung volumes, and chest radiographs were normal for both patients when they were asymptomatic and had implemented avoidance measures. Methacholine challenge was positive in one patient (PC(20) = 0.13 mg/mL). Both workers took appropriate respiratory protection measures during powder exposure and their symptoms improved. Enzyme powder used in cheese production is a trigger for OA.


Subject(s)
Allergens , Asthma/immunology , Cheese , Enzymes/immunology , Food-Processing Industry , Occupational Diseases/immunology , Occupational Exposure , Adrenal Cortex Hormones/therapeutic use , Adult , Asthma/physiopathology , Asthma/prevention & control , Bronchial Provocation Tests , Female , Humans , Occupational Diseases/physiopathology , Occupational Diseases/prevention & control , Powders , Respiratory Function Tests , Respiratory Protective Devices , Skin Tests
4.
Allergy Asthma Proc ; 28(4): 480-4, 2007.
Article in English | MEDLINE | ID: mdl-17883919

ABSTRACT

Nickel allergy (NA) is common and causes more cases of allergic contact dermatitis (ACD) than all other metals combined. Many orthodontic appliances (ODAs) contain nickel but their clinical relevance in nickel-allergic patients is unclear. We aimed to characterize the relationship between NA and ODAs because the medical literature investigating this is controversial. A survey concerning adverse reactions to ODAs in patients with NA was distributed to members of the Wisconsin Society of Orthodontics. Forty-three surveys were analyzed. The surveyed group was experienced, representing a mean of 21.2 years in practice and averaging 242 appliances placed per year per orthodontist. Most new patients with orthodontia were 10-18 years old. Most wires used were nickel-titanium alloy. Although 76% of orthodontists inquired about NA at initial evaluation, 37% still placed nickel-containing ODAs in known nickel-allergic patients. Fifty percent placed a single intraoral appliance, observing for reactions. Three orthodontists applied ODAs to the skin similar to patch testing. Only 8 patients with reactions to ODAs were described in detail, 6 were female patients and 6 were aged 13-14 years. Intraoral and extraoral reactions were mild; diffuse urticaria was reported in one patient. Treatment included removing the appliances or changing to nonnickel alternatives with favorable outcomes. These cases, which included >33,000 patients, suggest a prevalence of 0.03%. Adverse reactions to ODAs in patients with NA have been observed but are uncommon. Using suitable alternatives, patients usually can be accommodated.


Subject(s)
Hypersensitivity/etiology , Nickel/adverse effects , Orthodontic Appliances/adverse effects , Adolescent , Child , Data Collection , Dermatitis, Contact/etiology , Female , Humans , Male , Nickel/immunology , Patch Tests , Prevalence , Urticaria/chemically induced , Urticaria/etiology
5.
Expert Rev Clin Immunol ; 3(1): 47-55, 2007 Jan.
Article in English | MEDLINE | ID: mdl-20476951

ABSTRACT

Occupational asthma (OA) accounts for at least 10% of cases of adult asthma and presents as intermittent asthma occurring at the workplace and remitting on weekends and holidays, or persistent asthma, especially if the diagnosis and early intervention is delayed. OA is under-recognized, challenging and time-consuming to diagnose, difficult to confirm with currently available tests and complex in terms of legal implications of disability and impairment. Over 400 agents have been identified as causing OA with allergic triggers accounting for 80-90% of cases. Managing the worker with OA is demanding as it requires the most thorough evaluation with attention to detail to provide an accurate diagnosis and develop a thoughtful treatment recommendation. This frequently has to occur in the context of various competing entities including management, unions, insurance carriers and attorneys. The primary goal is excellent employee health through interventions that may allow the worker to continue in their occupation safely. Primary, secondary and tertiary prevention measures have been adopted for various types of OA with success. Novel approaches may become available and be beneficial to identify and treat OA early before severe, chronic, unremitting and irreversible changes occur.

6.
WMJ ; 105(7): 47-50, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17163087

ABSTRACT

We present a case of hypersensitivity pneumonitis in a 46-year-old female working at a yacht manufacturing company. She reported a 2-month history of progressive dyspnea, chest tightness, and daytime, nocturnal, and exertional cough in temporal relationship to work where she was exposed to chemicals involved in the manufacture of yachts. Treatment with systemic antibiotic therapy, inhaled bronchodilators, and inhaled corticosteroids provided minimal relief of symptoms. Spirometry revealed a restrictive defect and a chest x-ray demonstrated a diffuse interstitial pattern. She improved on oral corticosteroids and with avoidance of her work environment had resolution of her symptoms and normalization of her spirometry. Among the various chemicals the patient was exposed to, the most likely causative agents for her symptoms were dimethyl phthalate and styrene. Although the specific chemical or antigen could not be determined, the history and objective findings are consistent with occupational hypersensitivity pneumonitis. This represents a case of hypersensitivity pneumonitis related to the manufacture of yachts.


Subject(s)
Alveolitis, Extrinsic Allergic/chemically induced , Ships , Alveolitis, Extrinsic Allergic/diagnosis , Alveolitis, Extrinsic Allergic/drug therapy , Alveolitis, Extrinsic Allergic/physiopathology , Diagnosis, Differential , Female , Humans , Middle Aged , Phthalic Acids/toxicity , Respiratory Function Tests , Styrene/toxicity
7.
Pediatrics ; 118(5): 1925-31, 2006 Nov.
Article in English | MEDLINE | ID: mdl-17079563

ABSTRACT

BACKGROUND: Recurrent respiratory papillomatosis in children is an uncommon but potentially life-threatening benign tumor of the respiratory tract with laryngeal predilection. The diagnosis of recurrent respiratory papillomatosis may be challenging unless there is a high index of suspicion and awareness of the variable presentations. METHODS: We reviewed the medical charts of children with recurrent respiratory papillomatosis treated at a tertiary children's hospital. The presentation of recurrent respiratory papillomatosis is illustrated by a series of case reports. We provide a paradigm to assist in the early diagnosis of children with recurrent respiratory papillomatosis. RESULTS: Five patients, aged 2 to 6 years, were erroneously diagnosed with recurrent croup, asthma, laryngeal hemangioma, and tracheomalacia after presenting with variable degrees of chronic dyspnea, cough, stridor, dysphonia, weak cry, and syncope. Once the diagnosis of recurrent respiratory papillomatosis was made, recurring surgical ablation of papillomata was initiated. CONCLUSIONS: Any child presenting with a voice disturbance with or without stridor is recommended to have diagnostic flexible fiber-optic laryngoscopy. Recurrent respiratory papillomatosis should be considered in children when other common pediatric airway diseases either do not follow the natural history or do not respond to treatment of the common disorder.


Subject(s)
Laryngeal Neoplasms/diagnosis , Neoplasm Recurrence, Local/diagnosis , Papilloma/diagnosis , Respiratory Tract Diseases/diagnosis , Child , Child, Preschool , Diagnosis, Differential , Female , Humans , Male
8.
Ann Allergy Asthma Immunol ; 97(1): 110-2, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16892791

ABSTRACT

BACKGROUND: Anthrax vaccine was licensed in 1970 and is used to protect individuals exposed to biological warfare and those who may come in contact with Bacillus anthracis in infected animals or in laboratory settings. The current adsorbed anthrax vaccine is regarded as effective and safe. Adverse effects reported include fever, chills, myalgia, arthralgia, and nausea. Four cases of rheumatoid arthritis (RA) temporally related to anthrax vaccine have been reported. As the number of administered doses increases, a better understanding of its adverse events profile will be forthcoming. OBJECTIVE: To describe another patient with RA temporally related to anthrax vaccination. METHODS: A 42-year-old man developed bilateral knee stiffness and pain in all the proximal interphalangeal joints 5 days after receiving the first dose of anthrax vaccine. He reported chills, fever, and joint and neck pain, with a tender nodule at the injection site after dose 2. Hours after receiving dose 3 he experienced fever, chills, nausea, vomiting, and neck, hand, and shoulder pain. The vaccination series was terminated after the third dose. RESULTS: Physical examination revealed moderate swelling and tenderness of his bilateral proximal interphalangeal joints. His complete blood cell count was normal; rheumatoid factor level, 198 IU/mL; erythrocyte sedimentation rate, 53 mm/h; antinuclear antibodies, negative; C-reactive protein level, 2.7 mg/L; and anti-cyclic citrullinated peptide antibody level, 168 EU. Radiographs revealed mild degenerative changes in his hands and knees bilaterally. CONCLUSIONS: This case represents a fifth patient with RA temporally related to anthrax vaccine.


Subject(s)
Anthrax Vaccines/adverse effects , Arthritis, Rheumatoid/etiology , Adult , Arthralgia/etiology , Arthritis, Rheumatoid/diagnosis , Chills/etiology , Fever/etiology , Humans , Immunization, Secondary , Male , Vaccination , Vomiting/etiology
9.
WMJ ; 105(5): 50-2, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16933414

ABSTRACT

INTRODUCTION: While allergic reactions to poultry products in the form of feathers and eggs are common, allergic reactions to chicken meat are rare. Despite the popularity of chicken in today's healthy diet, severe reactions after ingesting chicken meat are rarely described. This report describes a patient who developed chicken meat anaphylaxis without experiencing allergy to eggs or feathers. METHODS: A carefully obtained history from a 41-year-old male suggested chicken meat as the cause of his symptoms. He developed abdominal cramping, generalized urticaria, and chest tightness after ingestion of chicken meat. Percutaneous allergy skin testing with commercial chicken and turkey extract and freshly cooked chicken utilizing the prick-prick test was performed. RESULTS: Skin testing was positive with all extracts of chicken and turkey in the patient, and negative in 4 healthy adult controls. Skin tests with feather and egg extract were negative. CONCLUSION: This is the third report of severe allergy to chicken meat in the absence of egg allergy. Physicians should be aware of the presence of chicken allergy without concomitant feather or egg allergy, particularly in adults.


Subject(s)
Food Hypersensitivity/diagnosis , Meat/adverse effects , Adult , Animals , Chickens , Diagnosis, Differential , Humans , Male , Skin Tests
10.
Indian J Chest Dis Allied Sci ; 48(2): 115-28, 2006.
Article in English | MEDLINE | ID: mdl-16696526

ABSTRACT

Hypersensitivity pneumonitis (HP) or extrinsic allergic alveolitis is a non-IgE mediated hypersensitivity disease initiated by inhalation and subsequent sensitisation to organic antigens. These diseases have been described in different occupational groups and present in acute, subacute or chronic forms based on the exposure to antigens and host response. Clinical features are dependent upon the stage of the disease and can include fever, chills, cough, dyspnoea, and weight loss. The immunopathogenesis involves both cellular immunity and antibody responses to inhaled antigens. Antibody response to the implicated antigen can be demonstrated in HP patients, but such antibodies are also detected in antigen exposed asymptomatic individuals. Bronchoalveolar lavage demonstrates lymphocytosis and preponderance of CD8+ cells. Pulmonary function studies demonstrate a restrictive pattern with diffusion defects. The diagnosis is difficult as no single test is confirmatory, hence information from clinical, radiological, physiological, and immunological evaluations may be used together for a confirmative diagnosis of hypersensitivity pneumonitis. The treatment of choice is avoidance of antigen but systemic corticosteroids may be effective in suppressing the inflammatory response. The prognosis depends on early diagnosis and effective antigen avoidance.


Subject(s)
Alveolitis, Extrinsic Allergic/diagnosis , Alveolitis, Extrinsic Allergic/immunology , Alveolitis, Extrinsic Allergic/therapy , Humans
11.
Clin Mol Allergy ; 3: 14, 2005 Oct 27.
Article in English | MEDLINE | ID: mdl-16253140

ABSTRACT

BACKGROUND: Allergic sensitization and reactions to guinea pig (Cavia porcellus) have been well documented in laboratory animal handlers, primarily manifesting as rhinitis, conjunctivitis, and asthma. Severe allergic reactions, however, are rare. METHODS: We report two patients with severe allergic reactions following non-occupational exposure to guinea pigs. The first patient, an 11-year-old female, developed ocular, nasal, skin and laryngeal edema symptoms immediately after handling a guinea pig. The second patient, a 24-year-old female, developed symptoms of isolated laryngeal edema after cleaning a guinea pig cage. Percutaneous skin testing, RAST, ELISA and ELISA inhibition testing with guinea pig extract were performed. RESULTS: Both patients had IgE-mediated allergy to guinea pig confirmed by ELISA and either RAST or skin testing. ELISA inhibition studies confirmed the specificity of the IgE reactivity to guinea pig. CONCLUSION: Severe IgE-mediated reactions can occur following non-occupational guinea pig exposure. Physicians should be aware of this possibility.

12.
Ann Allergy Asthma Immunol ; 94(2): 234-9, 2005 Feb.
Article in English | MEDLINE | ID: mdl-15765738

ABSTRACT

BACKGROUND: "Toxic mold syndrome" is a controversial diagnosis associated with exposure to mold-contaminated environments. Molds are known to induce asthma and allergic rhinitis through IgE-mediated mechanisms, to cause hypersensitivity pneumonitis through other immune mechanisms, and to cause life-threatening primary and secondary infections in immunocompromised patients. Mold metabolites may be irritants and may be involved in "sick building syndrome." Patients with environmental mold exposure have presented with atypical constitutional and systemic symptoms, associating those symptoms with the contaminated environment. OBJECTIVE: To characterize the clinical features and possible etiology of symptoms in patients with chief complaints related to mold exposure. METHODS: Review of patients presenting to an allergy and asthma center with the chief complaint of toxic mold exposure. Symptoms were recorded, and physical examinations, skin prick/puncture tests, and intracutaneous tests were performed. RESULTS: A total of 65 individuals aged 1 1/2 to 52 years were studied. Symptoms included rhinitis (62%), cough (52%), headache (34%), respiratory symptoms (34%), central nervous system symptoms (25%), and fatigue (23%). Physical examination revealed pale nasal mucosa, pharyngeal "cobblestoning," and rhinorrhea. Fifty-three percent (33/62) of the patients had skin reactions to molds. CONCLUSIONS: Mold-exposed patients can present with a variety of IgE- and non-IgE-mediated symptoms. Mycotoxins, irritation by spores, or metabolites may be culprits in non-IgE presentations; environmental assays have not been perfected. Symptoms attributable to the toxic effects of molds and not attributable to IgE or other immune mechanisms need further evaluation as to pathogenesis. Allergic, rather than toxic, responses seemed to be the major cause of symptoms in the studied group.


Subject(s)
Air Pollutants/immunology , Fungi/immunology , Hypersensitivity/etiology , Hypersensitivity/physiopathology , Adolescent , Adult , Child , Child, Preschool , Environmental Exposure , Female , Humans , Infant , Male , Middle Aged
14.
Clin Mol Allergy ; 3(1): 2, 2005 Jan 21.
Article in English | MEDLINE | ID: mdl-15663785

ABSTRACT

BACKGROUND: Asthma and sickle cell disease are common conditions that both may result in pulmonary complications. We hypothesized that children with sickle cell disease with concomitant asthma have an increased incidence of vaso-occlusive crises that are complicated by episodes of acute chest syndrome. METHODS: A 5-year retrospective chart analysis was performed investigating 48 children ages 3-18 years with asthma and sickle cell disease and 48 children with sickle cell disease alone. Children were matched for age, gender, and type of sickle cell defect. Hospital admissions were recorded for acute chest syndrome, cerebral vascular accident, vaso-occlusive pain crises, and blood transfusions (total, exchange and chronic). Mann-Whitney test and Chi square analysis were used to assess differences between the groups. RESULTS: Children with sickle cell disease and asthma had significantly more episodes of acute chest syndrome (p = 0.03) and cerebral vascular accidents (p = 0.05) compared to children with sickle cell disease without asthma. As expected, these children received more total blood transfusions (p = 0.01) and chronic transfusions (p = 0.04). Admissions for vasoocclusive pain crises and exchange transfusions were not statistically different between cases and controls. SS disease is more severe than SC disease. CONCLUSIONS: Children with concomitant asthma and sickle cell disease have increased episodes of acute chest syndrome, cerebral vascular accidents and the need for blood transfusions. Whether aggressive asthma therapy can reduce these complications in this subset of children is unknown and requires further studies.

17.
Curr Allergy Asthma Rep ; 3(5): 438-46, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12906783

ABSTRACT

There are more than 100000 recognized species of fungi, comprising 25% of the biomass of the earth. Allergic, IgE-induced, manifestations of airborne fungi are common, whereas non-IgE manifestations are rare. Recently, much focus has been placed on the non-IgE-mediated effects of various molds, including hypersensitivity pneumonitis, infectious disease, and mycotoxicoses. Hypersensitivity pneumonitis is a clinical syndrome associated with systemic and interstitial lung disease that occurs in susceptible individuals following fungal inhalation. Most fungi are not pathogenic to man; however, certain fungi are capable of infecting immunocompetent individuals. Although mycotoxins and exposure to mycotoxins ("toxic mold syndrome") are implicated in causing numerous, nonspecific, systemic symptoms, currently, there is no scientific evidence to support the allegation that human health is affected by inhaled mycotoxins. However, if mold is discovered in a home, school, or office setting, the source should be investigated and appropriate remediation undertaken to minimize structural damage and potential allergic sensitization.


Subject(s)
Alveolitis, Extrinsic Allergic/microbiology , Antigens, Fungal/adverse effects , Mycoses/microbiology , Mycotoxins/adverse effects , Air Microbiology , Alveolitis, Extrinsic Allergic/diagnosis , Alveolitis, Extrinsic Allergic/immunology , Alveolitis, Extrinsic Allergic/therapy , Food Microbiology , Humans , Mycoses/therapy
20.
Cutis ; 71(5): 396, 2003 May.
Article in English | MEDLINE | ID: mdl-12769407

ABSTRACT

We report the case of a 46-year-old man who tolerated 50 mg per day of cetirizine for the treatment of chronic idiopathic urticaria. The patient denied any sedation or somnolence and had no difficulty performing routine daily functions including driving. He had tried other antihistamines, including fexofenadine, loratadine, and hydroxyzine without improvement.


Subject(s)
Anti-Allergic Agents/therapeutic use , Cetirizine/therapeutic use , Urticaria/diagnosis , Urticaria/drug therapy , Anti-Allergic Agents/administration & dosage , Anti-Allergic Agents/adverse effects , Arm , Back , Cetirizine/administration & dosage , Cetirizine/adverse effects , Diagnosis, Differential , Drug Administration Schedule , Hand , Humans , Male , Middle Aged , Sleep Stages , Urticaria/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...